首页> 外文期刊>The American Journal of Human Genetics >Prioritizing genetic variants for causality on the basis of preferential linkage disequilibrium
【24h】

Prioritizing genetic variants for causality on the basis of preferential linkage disequilibrium

机译:在优先连锁不平衡的基础上优先考虑遗传变异的因果关系

获取原文
获取原文并翻译 | 示例
       

摘要

To date, the widely used genome-wide association studies (GWASs) of the human genome have reported thousands of variants that are significantly associated with various human traits. However, in the vast majority of these cases, the causal variants responsible for the observed associations remain unknown. In order to facilitate the identification of causal variants, we designed a simple computational method called the "preferential linkage disequilibrium (LD)" approach, which follows the variants discovered by GWASs to pinpoint the causal variants, even if they are rare compared with the discovery variants. The approach is based on the hypothesis that the GWAS-discovered variant is better at tagging the causal variants than are most other variants evaluated in the original GWAS. Applying the preferential LD approach to the GWAS signals of five human traits for which the causal variants are already known, we successfully placed the known causal variants among the top ten candidates in the majority of these cases. Application of this method to additional GWASs, including those of hepatitis C virus treatment response, plasma levels of clotting factors, and late-onset Alzheimer disease, has led to the identification of a number of promising candidate causal variants. This method represents a useful tool for delineating causal variants by bringing together GWAS signals and the rapidly accumulating variant data from next-generation sequencing.
机译:迄今为止,人类基因组的广泛使用的全基因组关联研究(GWAS)已经报告了成千上万种与各种人类特征显着相关的变异。但是,在绝大多数情况下,导致观察到的关联的因果变体仍然未知。为了便于识别因果变异,我们设计了一种简单的计算方法,称为“优先连锁不平衡(LD)”方法,该方法遵循GWAS发现的变异来查明因果变异,即使与发现相比很少见变体。该方法基于以下假设:与原始GWAS中评估的大​​多数其他变体相比,发现GWAS的变体在标记因果变体方面更好。将优惠的LD方法应用于因果变异已知的五个人类特征的GWAS信号上,我们成功地将已知的因果变异置于大多数情况下的前十名候选者中。将该方法应用于其他GWAS,包括丙型肝炎病毒治疗反应,血浆凝血因子水平和晚发性阿尔茨海默氏病等,已发现了许多有希望的候选因果变体。该方法代表了一种有用的工具,用于通过将GWAS信号和来自下一代测序的快速积累的变异数据汇总在一起来描绘因果变异。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号